Koncepo Scientech International

𝐁𝐢𝐨𝐀𝐬𝐢𝐚 2025 – 𝐂𝐚𝐭𝐚𝐥𝐲𝐬𝐭 𝐨𝐟 𝐂𝐡𝐚𝐧𝐠𝐞: 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 The 𝐓𝐞𝐥𝐚𝐧𝐠𝐚𝐧𝐚 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 once again brought together global visionaries, policymakers, and industry leaders at 𝐁𝐢𝐨𝐀𝐬𝐢𝐚 2025, setting the stage for transformative discussions on the future of healthcare, biotechnology, and life sciences. The event was inaugurated by 𝐇𝐨𝐧’𝐛𝐥𝐞 𝐂𝐡𝐢𝐞𝐟 𝐌𝐢𝐧𝐢𝐬𝐭𝐞𝐫 𝐨𝐟 𝐓𝐞𝐥𝐚𝐧𝐠𝐚𝐧𝐚, reinforcing the state's commitment to being a global hub for innovation and research in life sciences. This year’s conference featured insightful discussions on the future of life sciences, covering the 𝐞𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞, advancements in precision medicine, the transformative 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐀𝐈 𝐢𝐧 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, and India’s growing role in global healthcare innovation. The key sessions at BioAsia 2025 explored transformative trends in life sciences, from 𝐀𝐈-𝐝𝐫𝐢𝐯𝐞𝐧 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 to 𝐈𝐧𝐝𝐢𝐚’𝐬 𝐫𝐢𝐬𝐞 𝐚𝐬 𝐚 𝐠𝐥𝐨𝐛𝐚𝐥 𝐂𝐑𝐃𝐌𝐎 leader. Experts highlighted innovations in biotech, pharma, and medtech, the impact of 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐛𝐢𝐨𝐥𝐨𝐠𝐲 𝐨𝐧 𝐝𝐫𝐮𝐠 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 with WEF, and 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐭𝐨 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐈𝐧𝐝𝐢𝐚 𝐚𝐬 𝐚 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐡𝐮𝐛. The role of integrated healthcare in improving patient outcomes was also a key focus. Koncepo Scientech International is honored to have sponsored 𝐭𝐡𝐞 𝐩𝐚𝐧𝐞𝐥 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐨𝐧 "𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐞𝐜𝐨𝐧𝐨𝐦𝐲 𝐚𝐧𝐝 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐇𝐮𝐦𝐚𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐁𝐢𝐨𝐥𝐨𝐠𝐲" in collaboration with 𝐖𝐄𝐅. This session underscored the transformative role of generative biology in revolutionizing drug discovery, personalized medicine, and sustainable bio-manufacturing. 𝐒𝐨𝐦𝐞 𝐨𝐟 𝐨𝐮𝐫 𝐤𝐞𝐲 𝐥𝐞𝐚𝐫𝐧𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 𝐁𝐢𝐨𝐀𝐬𝐢𝐚 2025: ✅ The convergence of AI and biotechnology is accelerating drug development and precision medicine. ✅ India’s CRDMO sector is poised for exponential growth, with immense potential for global partnerships. ✅ Clinical trials in India present a multi-billion-dollar opportunity, but infrastructure and regulatory evolution are key. ✅ Collaborative ecosystems—between academia, industry, and policy stakeholders—will be the driving force behind future healthcare innovations. A big thank you to BioAsia 2025 and the Government of Telangana for orchestrating such an impactful event. The platform continues to inspire innovation and collaboration, strengthening India’s impact on global healthcare. Shakthi M Nagappan Telangana Life Sciences Sanjiv Navangul Marinna Madrid, PhD Dr.K.Anand Kumar World Economic Forum #BioAsia2025 #CatalystOfChange #LifeSciences #HealthcareInnovation #AIinHealthcare #ClinicalTrials #CRDMO #Bioeconomy #KoncepoScientech

The Indian medical devices market is experiencing robust growth, driven by rising healthcare awareness, government initiatives, and increasing medical tourism. The market is projected to grow at a CAGR of 5% from 2023 to 2033, with estimates reaching $26 billion by 2033. The sector's growth is fueled by the growing demand for advanced healthcare services, particularly in diagnostics, monitoring, and therapeutic devices. Major global players in India include Medtronic, GE Healthcare, Philips Healthcare, 3M, and Siemens Healthineers, alongside a growing number of local players like Trivitron Healthcare and Skanray Technologies, offering competitive, cost-effective solutions tailored to the Indian market. Technological advancements such as AI in diagnostics, wearable devices, and 3D printing for customized implants are accelerating industry evolution. In recent developments, India is witnessing more investments in manufacturing to reduce dependency on imports. The regulatory framework is governed by the CDSCO (Central Drugs Standard Control Organization), with an emphasis on ensuring the safety and quality of medical devices. India's Medical Device Rules (2017) offer clarity on device classification, approval processes, and quality standards. Market dynamics include a shift towards digital healthcare, rising healthcare expenditure, and a push for self-reliance in medical device manufacturing under initiatives like 'Make in India'.   #MedicalDevices #HealthcareInnovation #TechInHealthcare #MarketGrowth #MedicalTechnology #HealthcareTrends #RegulatoryCompliance #MedicalDevicesMarket #Koncepo

The 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 is witnessing growth driven by advancements in technology, an aging population, and increased healthcare demand. The market is projected to expand at a CAGR of 7.0% from 2024 to 2033, with an estimated value surpassing $800 billion by 2030. This growth is fueled by innovations in diagnostics, therapeutics, and patient monitoring systems. Key global players include Medtronic, Johnson & Johnson, Siemens Healthineers, GE Healthcare, and Philips Healthcare, who dominate through continuous product development, acquisitions, and strategic partnerships. The market is segmented into diagnostic devices, therapeutic devices, and monitoring devices, with the diagnostic segment holding the largest share due to the rising demand for early disease detection technologies. In terms of geographical presence, North America holds a substantial market share, but the Asia-Pacific region is expected to witness rapid growth due to expanding healthcare infrastructure. Technological advancements such as AI integration, minimally invasive surgery, wearable medical devices, and 3D printing are reshaping the industry. The development of personalized medicine and smart devices is gaining traction. Regulatory frameworks vary across regions, with the FDA, EMA, and other regulatory bodies enforcing stringent guidelines to ensure device safety and efficacy. Industry dynamics are also influenced by cost-containment pressures, the rise of homecare solutions, and the shift towards value-based care.   #MedicalDevices #HealthcareInnovation #TechInHealthcare #MarketGrowth #MedicalTechnology #HealthcareTrends #RegulatoryCompliance #MedicalDevicesMarket #Koncepo

𝐊𝐨𝐧𝐜𝐞𝐩𝐨 𝐒𝐜𝐢𝐞𝐧𝐭𝐞𝐜𝐡 𝐚𝐭 𝐁𝐢𝐨𝐀𝐬𝐢𝐚 2025 | 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐢𝐨𝐞𝐜𝐨𝐧𝐨𝐦𝐲   We are thrilled to announce our participation in BioAsia 2025, the premier life sciences and biotechnology conference shaping the future of global healthcare and innovation. This year, Koncepo Scientech International is proud to 𝐬𝐩𝐨𝐧𝐬𝐨𝐫 𝐚 𝐡𝐢𝐠𝐡-𝐢𝐦𝐩𝐚𝐜𝐭 𝐩𝐚𝐧𝐞𝐥 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 in collaboration with the 𝐖𝐨𝐫𝐥𝐝 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐅𝐨𝐫𝐮𝐦 (𝐖𝐄𝐅) on: 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐞𝐜𝐨𝐧𝐨𝐦𝐲 & 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐇𝐮𝐦𝐚𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 Biotechnology stands at a critical juncture, driven by rapid technological progress and shifting global dynamics in healthcare and life sciences. While breakthroughs like generative biology and biomanufacturing have the potential to transform the sector, challenges such as resource limitations, knowledge gaps, and structural disincentives persist. In parallel, Asia—and India in particular—are emerging as leaders in shaping the global biotech landscape, leveraging expertise in manufacturing and healthcare innovation. Our discussion will bring together leading voices from industry, research, and policy to explore how we can build a 𝐫𝐞𝐬𝐢𝐥𝐢𝐞𝐧𝐭, 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞, 𝐚𝐧𝐝 𝐢𝐧𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐛𝐢𝐨𝐞𝐜𝐨𝐧𝐨𝐦𝐲 for the future. Join us as we engage in transformative conversations and shape the next chapter of biotechnology innovation. Stay tuned for more updates! #KoncepoScientech #BioAsia2025 #GenerativeBiology #Bioeconomy #LifeSciences #BiotechInnovation #WEF #FutureOfHealthcare

Koncepo Scientech International was honored to be part of the 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 2025, where visionary discussions and strategic collaborations paved the way for the future of biopharmaceutical innovation.   We extend our sincere gratitude to 𝐃𝐫. 𝐑𝐚𝐭𝐧𝐞𝐬𝐡 𝐉𝐚𝐢𝐧 for facilitating an insightful roundtable discussion with 𝐃𝐫. 𝐑𝐚𝐣𝐞𝐬𝐡 𝐆𝐨𝐤𝐡𝐚𝐥𝐞, 𝐒𝐞𝐜𝐫𝐞𝐭𝐚𝐫𝐲, 𝐃𝐁𝐓, and esteemed 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐥𝐞𝐚𝐝𝐞𝐫𝐬. This dialogue was a crucial step toward shaping strategies that will position 𝐈𝐧𝐝𝐢𝐚 𝐚𝐬 𝐚 𝐠𝐥𝐨𝐛𝐚𝐥 𝐥𝐞𝐚𝐝𝐞𝐫 𝐢𝐧 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧.   As underscored by 𝐏𝐫𝐢𝐦𝐞 𝐌𝐢𝐧𝐢𝐬𝐭𝐞𝐫 𝐍𝐚𝐫𝐞𝐧𝐝𝐫𝐚 𝐌𝐨𝐝𝐢’𝐬 participation in the 𝐀𝐈 𝐀𝐜𝐭𝐢𝐨𝐧 𝐒𝐮𝐦𝐦𝐢𝐭 𝐢𝐧 𝐏𝐚𝐫𝐢𝐬, artificial intelligence is set to revolutionize key sectors, particularly healthcare. Advancing 𝐀𝐈-𝐝𝐫𝐢𝐯𝐞𝐧 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐝𝐚𝐭𝐚 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐢𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭—alongside a strong, skilled workforce—will be essential to accelerating India's leadership in 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧.   At Koncepo Scientech International, we remain committed to being a part of this transformation by delivering our expertise with excellence and innovation. Sanjay Singh Subodh Deshmukh Rahul Singhvi Prem Pavoor Sanjiv Navangul Cyrus Karkaria Atin Tomar Himanshu Gadgil Anurag Rathore Rajesh Gokhale Manoj Kumar R Panicker Gautham Nadig Dhananjay Nawandar Nitin Deshmukh Krishna Chandran Sridevi Khambhampaty Ratnesh Jain #Biologics2025 #Innovation #Collaboration #Biopharmaceuticals #HealthcareInnovation

The 𝐠𝐥𝐨𝐛𝐚𝐥 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐩𝐚𝐜𝐤𝐚𝐠𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 is experiencing significant growth, driven by increasing demand for innovative, secure, and sustainable packaging solutions. The market is projected to grow at a compound annual growth rate (CAGR) of approximately 12% over the next few years, fueled by the rising demand for biologics, personalized medicine, and the need for temperature-sensitive packaging solutions. Key global players in the pharmaceutical packaging sector include Amcor, Gerresheimer, West Pharmaceutical Services, and Schott AG, among others, who lead the market with innovative and efficient packaging technologies. The market is segmented into primary, secondary, and tertiary packaging, with primary packaging dominating the market due to its critical role in ensuring drug safety, integrity, and patient compliance. Technological advancements such as smart packaging, digitalization, automation, and the use of IoT-enabled solutions are reshaping the industry. These innovations are enhancing supply chain transparency, improving drug traceability, and addressing issues related to counterfeiting and product tampering. The regulatory framework in the pharmaceutical packaging market is becoming increasingly stringent, with global standards such as Good Manufacturing Practices (GMP) and the Drug Supply Chain Security Act (DSCSA) influencing packaging design and processes. Sustainability and eco-friendly packaging materials are gaining prominence, with companies focusing on biodegradable, recyclable, and low-carbon-footprint options. Recent industry developments include advancements in tamper-evident packaging, child-resistant solutions, and packaging for biologics and vaccines. As the pharmaceutical packaging landscape continues to evolve, these trends will shape the future of the market.   #PharmaceuticalPackaging #PackagingInnovation #Biologics #SmartPackaging #Sustainability #PharmaIndustry #PackagingSolutions #RegulatoryCompliance #Koncepo

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐌𝐞𝐞𝐭: 𝐈𝐧𝐯𝐞𝐬𝐭 𝐊𝐚𝐫𝐧𝐚𝐭𝐚𝐤𝐚 2025 | 𝐑𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐨𝐧 𝐊𝐖𝐈𝐍 𝐂𝐢𝐭𝐲 We are honored to join the 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐌𝐞𝐞𝐭: 𝐈𝐧𝐯𝐞𝐬𝐭 𝐊𝐚𝐫𝐧𝐚𝐭𝐚𝐤𝐚 2025 | 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞, engaging with esteemed dignitaries from the Government of Karnataka to shape the future of innovation-driven growth. Koncepo Scientech International is privileged to participate in this exclusive roundtable invitation. "𝐑𝐞𝐢𝐦𝐚𝐠𝐢𝐧𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡" embodies Karnataka’s vision for tech-driven, green, inclusive, and resilient development, reinforcing the state’s leadership in innovation and sustainability. A key highlight of the discussion was 𝐊𝐖𝐈𝐍 𝐂𝐢𝐭𝐲 (𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞, 𝐖𝐞𝐥𝐥𝐛𝐞𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐂𝐢𝐭𝐲)—a visionary initiative by the Government of Karnataka, strategically located just 50 km from Bengaluru. Designed to be a global hub for innovation, research, and education, KWIN City is set to redefine industry-academia collaboration and ecosystem development. As pioneers in setting up 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐩𝐚𝐫𝐤𝐬 𝐚𝐧𝐝 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦𝐬, Koncepo Scientech International actively contributed to the discussions, focusing on: ✅ Creating a cohesive ecosystem with infrastructure, asset mix, and application groups ✅ Prioritizing key sectors like Agri-Food and Biotechnology while ensuring regulatory excellence ✅ Infusing financial capital and integrating workforce development for long-term sustainability The exchange of ideas was truly insightful and engaging, and we look forward to further collaborations in driving Karnataka’s vision forward. A sincere thank you to the organizers for this fantastic opportunity! Priyank M Kharge Dinesh Gundu Rao D.K. Shivakumar M.B. Patil Gunjan Krishna Dr. Ekroop Caur Parnika Pavanram #InvestKarnataka2025 #Innovation #LifeSciences #Biotechnology #SustainableGrowth #KWINCity #KarnatakaVision #

𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐚𝐭 𝐭𝐡𝐞 5𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩, 𝐆𝐨𝐚 (Jan 30-31, 2025) Koncepo Scientech International recently had the privilege of participating in the 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩 2025 held in Goa from January 30-31—a platform that brought together industry leaders, researchers, and innovators to discuss the evolving landscape of biologics. The workshop provided deep insights into 𝐧𝐞𝐱𝐭-𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐛𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠, 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐭𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐜𝐞𝐥𝐥 & 𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 𝐚𝐧𝐝 𝐛𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬. Our team had engaging discussions on 𝐬𝐜𝐚𝐥𝐢𝐧𝐠 𝐮𝐩 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧, 𝐨𝐯𝐞𝐫𝐜𝐨𝐦𝐢𝐧𝐠 𝐩𝐫𝐨𝐜𝐞𝐬𝐬 𝐛𝐨𝐭𝐭𝐥𝐞𝐧𝐞𝐜𝐤𝐬, 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐀𝐈 & 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐛𝐢𝐨𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠. We extend our gratitude to the organizers, speakers, and fellow participants for fostering meaningful collaborations. As we move forward, 𝐊𝐨𝐧𝐜𝐞𝐩𝐨 𝐒𝐜𝐢𝐞𝐧𝐭𝐞𝐜𝐡 remains committed to advancing biologics innovation and supporting the industry with 𝐜𝐮𝐭𝐭𝐢𝐧𝐠-𝐞𝐝𝐠𝐞 𝐢𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐚𝐝𝐯𝐢𝐬𝐨𝐫𝐲 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞. #Biologics #Biomanufacturing #Biosimilars #CellandGeneTherapy #KoncepoScientech #Innovation #NextGenBiologics #Biologicsworkshop2025 #ictmumbai #bsw25 #biopharma #nanomedicinegroup

𝐃𝐞𝐜𝐨𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝐈𝐧𝐝𝐢𝐚𝐧 𝐔𝐧𝐢𝐨𝐧 𝐁𝐮𝐝𝐠𝐞𝐭 2025-26: 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐨𝐫 𝐏𝐡𝐚𝐫𝐦𝐚 & 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 The much-anticipated Union Budget 2025-26 has set the stage for India's pharmaceutical and biopharma sector with policies aimed at fostering innovation, self-reliance, and global competitiveness. As the industry stands at the intersection of R&D advancements, regulatory reforms, and manufacturing excellence, here are the key highlights that will shape the sector: 🔹 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐑&𝐃 𝐈𝐧𝐜𝐞𝐧𝐭𝐢𝐯𝐞𝐬: A dedicated Pharma Innovation Fund announced to boost research in biologics, biosimilars, and novel therapies. 🔹 𝐏𝐋𝐈 3.0 & 𝐁𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐁𝐨𝐨𝐬𝐭: Strengthening of the Production Linked Incentive (PLI) scheme, with a focus on high-value biologics, monoclonal antibodies, and cell & gene therapies. 🔹 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐅𝐚𝐬𝐭-𝐓𝐫𝐚𝐜𝐤𝐢𝐧𝐠 & 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡: Streamlining of clinical trial approvals and digital transformation in regulatory processes to enhance India’s ease of doing business in life sciences. 🔹 𝐀𝐏𝐈 & 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐒𝐞𝐥𝐟-𝐑𝐞𝐥𝐢𝐚𝐧𝐜𝐞: Increased funding for bulk drug parks and biotechnology clusters to reduce import dependency on critical raw materials. 🔹 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 & 𝐄𝐱𝐩𝐨𝐫𝐭 𝐆𝐫𝐨𝐰𝐭𝐡: Special incentives for pharma exports, particularly in emerging markets, along with enhanced support for GMP compliance & regulatory harmonization. This budget underscores 𝐈𝐧𝐝𝐢𝐚’𝐬 𝐜𝐨𝐦𝐦𝐢𝐭𝐦𝐞𝐧𝐭 𝐭𝐨 𝐛𝐞𝐜𝐨𝐦𝐢𝐧𝐠 𝐚 𝐠𝐥𝐨𝐛𝐚𝐥 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐩𝐨𝐰𝐞𝐫𝐡𝐨𝐮𝐬𝐞, accelerating investment in cutting-edge therapies while ensuring affordability and accessibility. Would love to hear your thoughts! How do you see these reforms impacting the future of pharma & biopharma in India? Let’s discuss. marketing@koncepo.com #UnionBudget2025 #Pharma #Biopharma #LifeSciences #MakeInIndia #Innovation #Healthcare #RandD #Selfreliance #

We're #hiring a new Sales Manager – Market Research & Market Intelligence in Bengaluru, Karnataka. Apply today or share this post with your network.